Ethics in Transplantation Committee

The ISHLT Ethics in Transplantation Committee advises the Board of Directors as needed on ethical issues in transplantation. It addresses matters referred by the Board and may pursue issues it identifies with Board approval.

ISHLT members can log in to see contact information for each of the committee members and representatives listed below. Only ISHLT members have access to this information.

Olivia Kates, MD, MA

Olivia Kates, MD, MA (2028)

Chair

Johns Hopkins University
Baltimore, MD USA
Savitri Fedson, MD, MA

Savitri Fedson, MD, MA (2027)

Past Chair

Michael E. DeBakey VA Medical Center
Houston, TX USA
David Bearl, MD, MA

David Bearl, MD, MA (2028)

Member

Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, TN USA
John Dark, MB, FRCS, ISHLTF

John Dark, MB, FRCS, ISHLTF (2027)

Member

Newcastle University
Hexham, United Kingdom
Kavita Dave, FRCP, MBBS

Kavita Dave, FRCP, MBBS (2028)

Member

Harefield Hospital
Milton Keynes, United Kingdom
Edward Garrity, MD

Edward Garrity, MD (2029)

Member

The University of Chicago
La Grange, IL USA
Tomoko Kato, MD, PhD

Tomoko Kato, MD, PhD (2029)

Member

Kurume University School of Medicine
Kurume-Shi, Japan
Cecilia Nucci, RN BSN

Cecilia Nucci, RN BSN (2028)

Member

Montefiore Medical Center
New York, NY USA
Brian Wayda, MD, MPH

Brian Wayda, MD, MPH (2029)

Member

NYU Grossman School of Medicine
New York, NY USA
Barbara Wilkey, BSN, MPAS, MD, ISHLTF

Barbara Wilkey, BSN, MPAS, MD, ISHLTF (2029)

Member

University of Colorado
Denver, CO USA
Greg Schultz, CAE

Greg Schultz, CAE

ISHLT Chief Executive Officer

ISHLT
Chicago, IL USA

The ISHLT Ethics in Transplantation Committee advises the Board of Directors as needed on ethical issues in transplantation. It addresses matters referred by the Board and may pursue issues it identifies with Board approval. Its scope includes promoting consistent adherence to ISHLT’s ethical standards in scientific presentations, publications, and collaborations conducted under the Society’s auspices, developing ISHLT position statements on transplant ethics, and working with organizations that share ISHLT’s values to advance ethical practices aligned with the Society’s mission.

Policies

Committee Composition
Committee Composition

The Ethics Committee will number no fewer than 5 and no more than 10 members.

  • A Board member will be appointed by the president to serve as chair the committee. Chairs will serve a one-year term and are eligible to serve up to three consecutive terms.
  • The chair will select a co-chair and populate the committee, with input from the board and staff to include members with specific expertise or interest in ethical issues.
  • The committee members should include balanced geographic, gender and professional specialty representation and one Early Career member.
  • The Executive Committee approves chair’s proposed committee members.
  • Committee members will serve a one-year term with no limits on subsequent terms.
  • The CEO or other senior staff member will serve as an ex officio member of the committee.
Committee Responsibilities
Committee Responsibilities

The Ethics Committee serves as an as-needed body to address issues referred by the Board or generated by the committee and pursued with Board approval.

  • Ethical compliance and consistency in the presentation, publication, or collaborative work on science under the auspices of ISHLT.
  • ISHLT position statements related to ethical issues in transplantation.
  • Collaborations with like-minded organizations for external promotion or advancement of ethical issues that are specific to ISHLT’s mission and values.
  • To recommend strategies to the Board that advance ISHLT’s goal of fostering an ethical, diverse, and inclusive organization.